No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.
No article has been written about this topic yet.
Be the first one to add some text.
Loading AI-assisted edit mode...
Timeline
January 2018
Aprinoia Therapeutics raises a $11,100,000 series B round from DCI Partners, KTB Network, ShangPharma and TaiAn Technologies.
Funding rounds
Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Insilico Medicine Hong Kong Limited
December 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's...
APRINOIA Therapeutics
December 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- APRINOIA Therapeutics Inc. today announced that they had executed a worldwide non-exclusive licensing agreement for Biogen Inc. (Nasdaq: BIIB)...
Is a
Company attributes
Founder
Crunchbase
Pitchbook
Legal name
Aprinoia Therapeutics Inc
Founded date
May 20, 2015
Total funding amount (USD)
11,100,000
Latest funding round date
January 2018
Other attributes
Headquarters
Categories
Related Topics
Contributors
- 1
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 2
Aleksander Holm
Interested in understanding the world we live in. - 3
Lax Mariappan
Technopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry.